A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/74 (2006.01) A23C 9/152 (2006.01) A23L 1/03 (2006.01)
Patent
CA 2213434
Cryptosporidium parvum (the cause of cryptosporidiosis) has become one of the most common enteropathogens causing diarrhea worldwide. Symptoms associated with cryptosporidiosis are very debilitating especially in the immunocompromised subject (e.g., AIDS patient). Clinical features include severe, chronic diarrhea, abdominal cramps, fatigue, weight loss, etc. which lead to increased health care costs and increased mortality. There is disclosed herein a method of inhibiting the severity of Cryptosporidium parvum infection by enterally administering a therapeutically effective amount of Lactobacillus reuteri.
Le Cryptosporidium parvum (à l'origine de la cryptosporidiose) est devenu un des entéropathogènes les plus communs, provoquant des diarrhées partout dans le monde. Les symptômes associés à la cryptosporidiose sont très débilitants, notamment chez les sujets immunodéprimés (tels que les patients atteints du SIDA). Les manifestations cliniques sont des diarrhées sévères, chroniques, des crampes abdominales, la fatigue, la perte de poids, etc., qui entraînent une hausse de la mortalité ainsi qu'une hausse des coûts relatifs aux soins médicaux et de santé. L'invention se rapporte à un procédé d'inhibition de la sévérité des infections dues à Cryptosporidium parvum qui consiste à administrer par voie entérale une quantité thérapeutiquement efficace de Lactobacillus reuteri.
Casas Ivan A.
Garleb Keith Allen
Wolf Bryan Warren
Abbott Laboratories
Biogaia Ab
Biogaia Biologics Ab
Smart & Biggar
LandOfFree
Use of lactobacillus reuteri to inhibit cryptosporidiosis in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of lactobacillus reuteri to inhibit cryptosporidiosis in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of lactobacillus reuteri to inhibit cryptosporidiosis in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1668581